Lebwohl MG, Stein Gold L, Strober B, Papp KA, Armstrong AW, Bagel J, et al

Disclosures: Kathryn del Valle: Nothing to Disclose, Dana Kay: Nothing to Disclose, Michael Krowka: Nothing to Disclose, James Runo: Nothing to Disclose, Corey Sadd: Nothing to Disclose, Julie Heimbach: Nothing to Disclose, Rodrigo Cartin-Ceba: Nothing to Disclose, Hector Cajigas: Nothing to Disclose, Charles Burger: INSMED: Consultant, GossamerBio: Consultant, Janssen: Consultant, John Moss: Nothing to Disclose, Hilary DuBrock: Nothing to Disclose 1309 SERUM AND URINARY METABOLOMICS ARE ASSOCIATED WITH THE DEVELOPMENT OF DE NOVO METABOLIC SYNDROME AFTER LIVER TRANSPLANT: A MULTI-CENTER LONGITUDINAL STUDY Jasmohan Bajaj 1 Isobel Jane Cox 2 Mette Munk Lauridsen 1 Adrien Le Guennec 3 Andrew Fagan 4 Geena George 5 Amy Bartels 1 Thresiamma Lukose 5 Elizabeth Verna 5 , 1 Virginia Commonwealth University, 2 Roger Williams Institute for Hepatology, 3 Kings College London, 4 Richmond VA Medical Center, 5 Columbia University Medical Center Background: Liver transplantation (LT) is associated with development of de novo metabolic syndrome (MetS) and adverse cardiovascular events over time

However, in some cases, it may cause certain mild side effects to people with highly sensitive skin
[149] Pre-agricultural Europeans appear to have had similar, or slightly higher, [147] percentages to modern East Asians, and the numbers may have decreased in the former due to dilution with a group of people which had split off before Neanderthal introgression